Latest Breaking News On - Neurological - Page 26 : comparemela.com

Welcome To IANS Live - LatestNews - Smartphone study reveals bodily rhythm affects behaviour

Researchers from the Leiden University in the Netherlands analysed the usage data of hundreds of mobile phones and discovered that the human body, both of men and women, has rhythms ranging between seven and 52 days. These cycles influence how we behave.

LondonCity ofUnited kingdomNetherlandsArko ghoshEnea ceoliniLeiden universityDigital medicineBehaviourPeopleCyclesInfluencePsychologicalNeurologicalResearchParticular

Lyon, France – 12 April 2023 – 6pm CEST – Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases and pioneer in the development of drug. | April 12, 2023

ParisFrance generalFranceChicagoIllinoisUnited statesFrenchWorldsymposium orlandoMarco sardielloInserm transfertMathieu charvEmyr lloyd evansClaude bernard lyonResearch associationCardiff university united kingdomBaylor college of medicine houston

International FND Awareness Day 2023: 4 to12 persons out of 100,000 are affected with the neurological disease

The aim of the week is to promote awareness, support affected individuals, and advance research for the prevention, treatment, and recovery of FND.

International functional neurological disorderAwareness dayNeurological disorderInternational fnd awareness day 2023OfndFunctional neurological disorderDiseaseNeurologicalNeurological diseaseWorldHealthLifetsyle

Ex-Komodo Health VP, Vivian DeWoskin, Joins NeuraLight As Chief Commercial Officer

Ex-Komodo Health VP, Vivian DeWoskin, Joins NeuraLight As Chief Commercial Officer
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

BerkeleyCaliforniaUnited statesTel avivIsraelVivian dewoskinMelissa moweryMicha breakstoneFlatiron healthWhile at komodo healthBusiness developmentInnovation award for healthTrinity life sciencesKomodo healthHead of strategy at komodo healthPrinceton university

Seelos Therapeutics Doses the First Amyotrophic Lateral Sclerosis (ALS) Patient with SLS-005 in an Expanded Access Program

- The Expanded Access Program is funded by a grant from the National Institute of Neurological Disorders and Stroke under the Accelerating Access to Critical Therapies for ALS for ALS patients who. | April 4, 2023

New yorkUnited statesAnthony marcianoMike moyerHuman servicesDrug administrationNasdaqPartnership for rare neurodegenerative diseasesExchange commissionLifesci advisorsNational institutes of healthDepartment of healthPrnewswire seelos therapeutics incNational institute of neurological disordersAccess programSeelos therapeutics inc